Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-14-001984
Filing Date
2014-01-09
Accepted
2014-01-09 16:15:20
Documents
1
Period of Report
2014-01-01

Document Format Files

Seq Description Document Type Size
1 INITAL FORM 3 rrd399459.html 3  
1 INITAL FORM 3 rrd399459.xml 3 3817
  Complete submission text file 0001181431-14-001984.txt   5470
Mailing Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000
Business Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000 353 1 6699 020
AMARIN CORP PLC\UK (Issuer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AMARIN PHARMA, INC. 1430 ROUTE 206, SUITE 200 BEDMINSTER NJ 07921
Business Address
Farrell Michael James (Reporting) CIK: 0001595763 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-21392 | Film No.: 14518966